FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX, a global leader in life science analytical technologies, today announced a global initiative focused on biologics. This new initiative is in response to the fundamental shift of the pharmaceutical industry into biopharmaceutical development. AB SCIEX’s BiologicsFocus Initiative consists of four components: new product development; beta software evaluation program; one-on-one connections program; and forums for sharing the latest advancements in biologics across the scientific community. The company revealed this initiative today at the International Mass Spectrometry Conference (IMSC) in Japan.
